title: [Duration of treatment against osteoporosis using bisphosphonate].
abstract: Through their effects on bone mineral density and bone remodeling, bisphosphonates reduce fracture risk, and are considered as the first choice treatment of patients with osteoporosis nowadays. Therapeutical controlled trials lasting up to 5 years are available. Beyond that duration, bisphosphonate treatment does not appear to be deleterious for bone.
authors.affiliation: Service des maladies osseuses Département de réhabilitation et gériatrie HUG. Rene.Rizzoli@medecine.unige.ch
authors.forename: René
authors.initials: R
authors.lastname: Rizzoli
mesh_terms: D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D004164:Diphosphonates